Multicentric reticulohistiocytosis successfully treated with baricitinib

Eur J Dermatol. 2022 Jul 1;32(4):539-540. doi: 10.1684/ejd.2022.4307.
No abstract available

MeSH terms

  • Azetidines* / therapeutic use
  • Histiocytosis, Non-Langerhans-Cell* / drug therapy
  • Humans
  • Purines / therapeutic use
  • Pyrazoles / therapeutic use

Substances

  • baricitinib
  • Azetidines
  • Purines
  • Pyrazoles